Effect of Different Heparinization Schemes on Prognosis of Intracranial Aneurysm (EODHS-IA)
Intracranial Aneurysm
About this trial
This is an interventional treatment trial for Intracranial Aneurysm focused on measuring Intracranial Aneurysm
Eligibility Criteria
Inclusion Criteria: Greater than 18 years old, less than 75 years old Patients with unruptured intracranial aneurysm were confirmed by DSA. Coagulation function should be normal in the enrolled patients. Exclusion Criteria: Dissection aneurysm, blister aneurysm, moyamoya disease or arteriovenous malformation. Previous use of antithrombotic drugs (including anticoagulant or antiplatelet aggregation drugs).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
Low-dose group
Medium dose group
High-dose group
The initial dose was 50U/kg intravenous injection, and the dosage was halved by intravenous injection every 1 hour to the minimum 1000u/h. The medication will be discontinued at the end of the procedure.
The initial dose was 60U/kg intravenous injection, and the dosage was halved by intravenous injection every 1 hour to the minimum 1000u/h. The medication will be discontinued at the end of the procedure.
The initial dose was 70U/kg intravenous injection, and the dosage was halved by intravenous injection every 1 hour to the minimum 1000u/h. The medication will be discontinued at the end of the procedure.